Key Takeaways
Extended Takeaways
- The vision screening-to-referral pathway appears active rather than absent in children with mental, emotional, developmental, or behavioral problems, with more than 60% undergoing vision screening by a non–eye provider; the clinical challenge may be what happens after referral, not just whether screening occurs.
- Referral intensity stayed elevated across 2021–2023, but the between-group gap for recommendations for an eye exam or additional services narrowed in 2023 as the MEDB group declined from 34.9% in 2021 and 35.4% in 2022 to 33.6% in 2023, with Δ shrinking from 9.5% to 10.5% to 7.2%.
- Functional vision problems did not clearly normalize despite greater system contact: the absolute gap in limitation despite correction ranged from 1.4 to 3.4 percentage points across 2019–2023, suggesting that psychiatrists should ask whether visual difficulties persist even when a child already has glasses or contact lenses.
- Unmet vision care need was uncommon in both groups across 2019–2023 and reached statistical significance only in 2020, so parent report of access alone may underestimate clinically relevant burden in children with major developmental or behavioral complexity.
- Because the MEDB indicator combines ADHD, anxiety/depression, autism spectrum disorder, developmental delay, and other conditions into a single composite, these findings are best used to heighten vigilance for ophthalmic comorbidity broadly rather than to infer risk for any one diagnosis.
